Literature DB >> 11160381

Schwann cell proliferative responses to cAMP and Nf1 are mediated by cyclin D1.

H A Kim1, N Ratner, T M Roberts, C D Stiles.   

Abstract

In most mammalian cells, the cAMP-dependent protein kinase A pathway promotes growth arrest and cell differentiation. However in Schwann cells, the reverse is true. Elevated levels of cAMP function as the cofactor to a broad range of mitogenic cues in culture and in animals. Previous studies have suggested that cAMP acts at an early point in the Schwann cell mitogenic response, perhaps by stimulating the expression of growth factor receptors. We show here that cAMP acts downstream rather than upstream of growth factor receptor expression. The essential function(s) of cAMP is exerted as Schwann cells progress through the G(1) phase of the cell cycle. Ectopic expression studies using an inducible retroviral vector show that the G(1) phase requirement for cAMP can be alleviated by a single protein, cyclin D1. We show, in addition, that at least one function of the Nf1 tumor suppressor is to antagonize the accumulation of cAMP and the expression of cyclin D1 in Schwann cells. Thus a G(1) phase-specific protein, cyclin D1, accounts for two salient features of Schwann cell growth control: the promitotic response to cAMP and the antimitotic response to the Nf1 tumor suppressor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160381      PMCID: PMC6762237     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  35 in total

1.  Induction of DNA synthesis in BALB/c 3T3 cells by serum components: reevaluation of the commitment process.

Authors:  W J Pledger; C D Stiles; H N Antoniades; C D Scher
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

Review 2.  Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age.

Authors:  T Hunter; J Pines
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

3.  Regulation of the Balb/c-3T3 cell cycle-effects of growth factors.

Authors:  C D Stiles; W J Pledger; R W Tucker; R G Martin; C D Scher
Journal:  J Supramol Struct       Date:  1980

4.  The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21.

Authors:  G A Martin; D Viskochil; G Bollag; P C McCabe; W J Crosier; H Haubruck; L Conroy; R Clark; P O'Connell; R M Cawthon
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

5.  Rescue of a Drosophila NF1 mutant phenotype by protein kinase A.

Authors:  I The; G E Hannigan; G S Cowley; S Reginald; Y Zhong; J F Gusella; I K Hariharan; A Bernards
Journal:  Science       Date:  1997-05-02       Impact factor: 47.728

6.  Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve.

Authors:  J P Brockes; K L Fields; M C Raff
Journal:  Brain Res       Date:  1979-04-06       Impact factor: 3.252

7.  Inhibition by cAMP of Ras-dependent activation of Raf.

Authors:  S J Cook; F McCormick
Journal:  Science       Date:  1993-11-12       Impact factor: 47.728

8.  Identification and purification of glial growth factor.

Authors:  G E Lemke; J P Brockes
Journal:  J Neurosci       Date:  1984-01       Impact factor: 6.167

9.  Platelet-derived growth factors and fibroblast growth factors are mitogens for rat Schwann cells.

Authors:  J B Davis; P Stroobant
Journal:  J Cell Biol       Date:  1990-04       Impact factor: 10.539

10.  cAMP antagonizes p21ras-directed activation of extracellular signal-regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor.

Authors:  B M Burgering; G J Pronk; P C van Weeren; P Chardin; J L Bos
Journal:  EMBO J       Date:  1993-11       Impact factor: 11.598

View more
  42 in total

Review 1.  Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms.

Authors:  Steven L Carroll
Journal:  Acta Neuropathol       Date:  2011-12-11       Impact factor: 17.088

2.  Schwann cell dedifferentiation is independent of mitogenic signaling and uncoupled to proliferation: role of cAMP and JNK in the maintenance of the differentiated state.

Authors:  Paula V Monje; Jennifer Soto; Ketty Bacallao; Patrick M Wood
Journal:  J Biol Chem       Date:  2010-07-15       Impact factor: 5.157

Review 3.  A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.

Authors:  Nancy Ratner; Shyra J Miller
Journal:  Nat Rev Cancer       Date:  2015-04-16       Impact factor: 60.716

4.  Non-antagonistic relationship between mitogenic factors and cAMP in adult Schwann cell re-differentiation.

Authors:  Paula V Monje; Sayuri Rendon; Gagani Athauda; Margaret Bates; Patrick M Wood; Mary Bartlett Bunge
Journal:  Glia       Date:  2009-07       Impact factor: 7.452

5.  In vitro modeling of hyperpigmentation associated to neurofibromatosis type 1 using melanocytes derived from human embryonic stem cells.

Authors:  Jennifer Allouche; Nathalia Bellon; Manoubia Saidani; Laure Stanchina-Chatrousse; Yolande Masson; Anand Patwardhan; Floriane Gilles-Marsens; Cédric Delevoye; Sophie Domingues; Xavier Nissan; Cécile Martinat; Gilles Lemaitre; Marc Peschanski; Christine Baldeschi
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-06       Impact factor: 11.205

Review 6.  Molecular targets for NF1-associated malignant peripheral nerve sheath tumor.

Authors:  Lama Binobaid; Michal M Masternak
Journal:  Rep Pract Oncol Radiother       Date:  2020-04-27

Review 7.  Targeted stimulation of MSCs in peripheral nerve repair.

Authors:  Femke Mathot; Alexander Y Shin; Andre J Van Wijnen
Journal:  Gene       Date:  2019-03-05       Impact factor: 3.688

8.  ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae.

Authors:  Florent Elefteriou; M Douglas Benson; Hideaki Sowa; Michael Starbuck; Xiuyun Liu; David Ron; Luis F Parada; Gerard Karsenty
Journal:  Cell Metab       Date:  2006-12       Impact factor: 27.287

Review 9.  Advances in peripheral nerve regeneration.

Authors:  Jami Scheib; Ahmet Höke
Journal:  Nat Rev Neurol       Date:  2013-11-12       Impact factor: 42.937

10.  Tissue-specific ablation of Prkar1a causes schwannomas by suppressing neurofibromatosis protein production.

Authors:  Georgette N Jones; Chhavy Tep; William H Towns; Georgeta Mihai; Ian D Tonks; Graham F Kay; Petra M Schmalbrock; Anat O Stemmer-Rachamimov; Sung Ok Yoon; Lawrence S Kirschner
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.